| abstract |
The invention relates to benzimidazoleacetic acid derivatives that act as antagonists of a molecule homologous to a chemoattractant receptor expressed on a Type 2 helper T cell receptor (CRTH2). The invention also relates to the use of these derivatives for inhibiting the binding of prostaglandin D and its metabolites or a number of thromboxane metabolites to the CRTH2 receptor and for treating disorders sensitive to this inhibition. |